RON KINASE AS POTENTIAL IMMUNOTHERAPEUTIC TARGET FOR AUGMENTING T CELL ACTIVITY IN BREAST CANCER METASTASIS

被引：0
|
作者：
Lai, Alicia [1 ]
Welm, Alana [1 ]
机构：
[1] Huntsman Canc Inst, Salt Lake City, UT USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1036
引用
收藏
页码：A1078 / A1078
页数：1
相关论文
共 50 条
  • [41] Breast cancer metastasis - a target for cyclooxygenase inhibitors?
    Schem, C.
    Bielefeld, T.
    Bauerschlag, D. O.
    Mundhenke, C.
    Jonat, W.
    Maass, N.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S175 - S175
  • [42] RON receptor tyrosine kinase in head and neck cancer: a potential target for overcoming resistance to anti-EGFR therapy
    Lu, Zhixin
    Takiar, Vinita
    Waltz, Susan E.
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Metabolic Heterogeneity and Potential Immunotherapeutic Responses Revealed by Single-Cell Transcriptomics of Breast Cancer
    Tang, Shicong
    Wang, Qing
    Sun, Ke
    Song, Ying
    Liu, Rui
    Tan, Xin
    Li, Huimeng
    Lv, Yafeng
    Yang, Fuying
    Zhao, Jiawen
    Li, Sijia
    Bi, Pingping
    Yang, Jiali
    Zhu, Zhengna
    Chen, Dong
    Chuan, Zhirui
    Luo, Xiaomao
    Hu, Zaoxiu
    Liu, Ying
    Li, Zhenhui
    Ke, Tengfei
    Jiang, Dewei
    Zheng, Kai
    Yang, Rirong
    Chen, Kai
    Guo, Rong
    APOPTOSIS, 2024, 29 (9-10) : 1466 - 1482
  • [44] C-Jun, a crucial molecule in metastasis of breast cancer and potential target for biotherapy
    Zhang, Yan
    Pu, Xiaoyun
    Shi, Ming
    Chen, Liyong
    Qian, Lu
    Song, Yuhua
    Yuan, Guogang
    Zhang, Hao
    Yu, Ming
    Hu, Meiru
    Shen, Beifen
    Guo, Ning
    ONCOLOGY REPORTS, 2007, 18 (05) : 1207 - 1212
  • [45] Suppression of Breast Cancer Bone metastasis by Osteocytic Connexin Hemichannels, a Potential Therapeutic Target
    Riquelme, Manuel
    Gu, Sumin
    An, Zhiqiang
    Jiang, Jean
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 73 - 73
  • [46] Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target
    Curty, Gislaine
    Marston, Jez L.
    Rougvie, Miguel de Mulder
    Leal, Fabio E.
    Nixon, Douglas F.
    Soares, Marcelo A.
    VIRUSES-BASEL, 2020, 12 (07):
  • [47] CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target
    Xiao, Cong
    Zhang, Xiaojuan
    Hou, Bobo
    Wan, Ping
    Cao, Zhenjun
    Rao, Xuefeng
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [48] CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
    Freile, Jimena Alvarez
    Avtenyuk, Natasha Ustyanovska
    Corrales, Macarena Gonzalez
    Lourens, Harm Jan
    Huls, Gerwin
    van Meerten, Tom
    Cendrowicz, Ewa
    Bremer, Edwin
    BIOMEDICINES, 2022, 10 (05)
  • [49] SIRP. BLOCKADE AS AN IMMUNOTHERAPEUTIC STRATEGY TO TREAT BREAST CANCER BRAIN METASTASIS
    Tsai, Yu-Ting
    Wilson, Adam
    Cook, Katherine
    Zhao, Dawen
    Lesser, Glenn
    Soto-Pantoja, David R.
    NEURO-ONCOLOGY, 2023, 25
  • [50] Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma
    Y. Zhang
    Q. Zhai
    X. Feng
    D. Chen
    Y. Lu
    J. Hu
    H. Xie
    L. Zhou
    J. Wu
    S. Zheng
    Clinical and Translational Oncology, 2021, 23 : 1314 - 1324
12345